Semplicini, C., Vissing, J., Dahlqvist, J. R., Stojkovic, T., Bello, L., Witting, N., Duno, M., Leturcq, F., Bertolin, C., D'Ambrosio, P., Eymard, B., Angelini, C., Politano, L., Laforet, P., Pegoraro, E. :
Clinical and genetic spectrum in limb-girdle muscular dystrophy type 2E
Neurology, 2015 ; 84 (17) : 1772-1781
Publications (1184)
Dieval, C., Deligny, C., Meyer, A., Cluzel, P., Champtiaux, N., Lefevre, G., Saadoun, D., Sibilia, J., Pellegrin, J. L., Hachulla, E., Benveniste, O., Hervier, B. :
Myocarditis in Patients With Antisynthetase Syndrome: Prevalence, Presentation, and Outcomes Medicine (Baltimore), 2015 ; 94 (26) : e798
Myocarditis in Patients With Antisynthetase Syndrome: Prevalence, Presentation, and Outcomes Medicine (Baltimore), 2015 ; 94 (26) : e798
Mescam-Mancini, L, Allenbach, Y, Hervier, B, Devilliers, H, Mariampillay, K, Dubourg, O, Maisonobe, T, Gherardi, R, Mezin, P, Preusse, C, Stenzel, W, Benveniste, O :
Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis. Brain, 2015 ; 138 (Pt 9) : 2485-92
Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis. Brain, 2015 ; 138 (Pt 9) : 2485-92
De Cid, R., Ben Yaou, R., Roudaut, C., Charton, K., Baulande, S., Leturcq, F., Romero, N. B., Malfatti, E., Beuvin, M., Vihola, A., Criqui, A., Nelson, I., Nectoux, J., Ben Aim, L., Caloustian, C., Olaso, R., Udd, B., Bonne, G., Eymard, B., Richard, I. :
A new titinopathy: Childhood-juvenile onset Emery-Dreifuss-like phenotype without cardiomyopathy Neurology, 2015 ; 85 (24) : 2126-35
A new titinopathy: Childhood-juvenile onset Emery-Dreifuss-like phenotype without cardiomyopathy Neurology, 2015 ; 85 (24) : 2126-35
Pinto-Mariz, F., Rodrigues Carvalho, L., Prufer De Queiroz Campos Araujo, A., De Mello, W., Goncalves Ribeiro, M., Cunha Mdo, C., Cabello, P. H., Riederer, I., Negroni, E., Desguerre, I., Veras, M., Yada, E., Allenbach, Y., Benveniste, O., Voit, T., Mouly, V., Silva-Barbosa, S. D., Butler-Browne, G., Savino, W. :
CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy Skelet Muscle, 2015 ; 5 : 45
CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy Skelet Muscle, 2015 ; 5 : 45
Kostallari, E., Baba-Amer, Y., Alonso-Martin, S., Ngoh, P., Relaix, F., Lafuste, P., Gherardi, R. K. :
Pericytes in the myovascular niche promote post-natal myofiber growth and satellite cell quiescence Development, 2015 ; 142 (7) : 1242-53
Pericytes in the myovascular niche promote post-natal myofiber growth and satellite cell quiescence Development, 2015 ; 142 (7) : 1242-53
Hogrel, J. Y. :
Grip strength measured by high precision dynamometry in healthy subjects from 5 to 80 years BMC Musculoskelet Disord, 2015 ; 16 : 139
Grip strength measured by high precision dynamometry in healthy subjects from 5 to 80 years BMC Musculoskelet Disord, 2015 ; 16 : 139
Al-Dabbagh, S., McPhee, J. S., Murgatroyd, C., Butler-Browne, G., Stewart, C. E., Al-Shanti, N. :
The lymphocyte secretome from young adults enhances skeletal muscle proliferation and migration, but effects are attenuated in the secretome of older adults Physiol Rep, 2015 ; 3 (11) :
The lymphocyte secretome from young adults enhances skeletal muscle proliferation and migration, but effects are attenuated in the secretome of older adults Physiol Rep, 2015 ; 3 (11) :
Bougerol, M., Aurade, F., Lambert, F. M., Le Ray, D., Combes, D., Thoby-Brisson, M., Relaix, F., Pollet, N., Tostivint, H. :
Generation of BAC Transgenic Tadpoles Enabling Live Imaging of Motoneurons by Using the Urotensin II-Related Peptide (ust2b) Gene as a Driver PLoS ONE, 2015 ; 10 (2) : e0117370
Generation of BAC Transgenic Tadpoles Enabling Live Imaging of Motoneurons by Using the Urotensin II-Related Peptide (ust2b) Gene as a Driver PLoS ONE, 2015 ; 10 (2) : e0117370
Orngreen, M. C., Vissing, J., Laforet, P. :
No effect of bezafibrate in patients with CPTII and VLCAD deficiencies J Inherit Metab Dis, 2015 ; 38 (2) : 373-374
No effect of bezafibrate in patients with CPTII and VLCAD deficiencies J Inherit Metab Dis, 2015 ; 38 (2) : 373-374
